Evidence map›Paper›PMID 33955571›Full record

ArticleStatistics in medicine2021

Nowcasting COVID-19 incidence indicators during the Italian first outbreak.

Pierfrancesco Alaimo Di Loro, Fabio Divino, Alessio Farcomeni, Giovanna Jona Lasinio, Gianfranco Lovison, Antonello Maruotti, Marco Mingione

Abstract read
In one paragraph

Article in Statistics in medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Social Health and Psychological Safety of Students Involved in Online Education during the COVID-19 Pandemic.International journal of environmental research and public health · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Estimating COVID-19-induced excess mortality in Lombardy, Italy.Aging clinical and experimental research · 2022
    Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Pierfrancesco Alaimo Di LoroDepartment of Statistical Sciences, University of Rome "La Sapienza", Rome, Italy.ORCID 0000-0002-6075-3659
Fabio DivinoDepartment of Bio-Sciences, University of Molise, Campobasso, Italy.
Alessio FarcomeniDepartment of Economics and Finance, University of Rome "Tor Vergata", Rome, Italy.ORCID 0000-0002-7104-5826
Giovanna Jona LasinioDepartment of Statistical Sciences, University of Rome "La Sapienza", Rome, Italy.ORCID 0000-0001-8912-5018
Gianfranco LovisonDepartment of Economics, Management and Statistics, University of Palermo, Palermo, Italy.ORCID 0000-0003-3861-8204
Antonello MaruottiDepartment of GEPLI, Libera Universitá Maria Ss Assunta, Rome, Italy.ORCID 0000-0001-8377-9950
Marco MingioneDepartment of Statistical Sciences, University of Rome "La Sapienza", Rome, Italy.ORCID 0000-0002-5662-3499

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A novel parametric regression model is proposed to fit incidence data typically collected during epidemics. The proposal is motivated by real-time monitoring and short-term forecasting of the main epidemiological indicators within the first outbreak of COVID-19 in Italy. Accurate short-term predictions, including the potential effect of exogenous or external variables are provided. This ensures to accurately predict important characteristics of the epidemic (e.g., peak time and height), allowing for a better allocation of health resources over time. Parameter estimation is carried out in a maximum likelihood framework. All computational details required to reproduce the approach and replicate the results are provided.

Indexed as

COVID-19Disease OutbreaksHumansIncidenceItalySARS-CoV-2COVID-19growth curvesRichards' equationSARS-CoV-2

Identifiers

PMID33955571
PMCPMC8242495

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.